| 2025-11-13 | Class II | Ganirelix Acetate | Ongoing |
| 2025-11-05 | Class II | Sertraline Hydrochloride | Ongoing |
| 2025-07-02 | Class II | Amlodipine Besylate And Benazepril Hydrochloride | Ongoing |
| 2025-06-27 | Class II | Clomipramine Hydrochloride | Terminated |
| 2025-06-20 | Class II | Lisinopril And Hydrochlorothiazide | Ongoing |
| 2025-04-10 | Class II | Clomipramine Hydrochloride | Terminated |
| 2024-12-20 | Class II | Levothyroxine Sodium | Terminated |
| 2024-10-23 | Class II | Ramipril | Terminated |
| 2024-10-23 | Class II | Ramipril | Terminated |
| 2024-10-23 | Class II | Ramipril | Terminated |
| 2024-08-21 | Class II | Cefixime | Terminated |
| 2024-05-30 | Class II | Cefixime | Terminated |
| 2024-05-08 | Class II | Cefdinir | Terminated |
| 2024-04-24 | Class II | Cefdinir | Terminated |
| 2024-04-24 | Class II | Cefdinir | Terminated |
| 2024-03-21 | Class II | Rifampin Capsules USP, 300mg, 30-count bottles, Rx only, Manufactured for: Lupin Pharmaceu | Terminated |
| 2024-02-05 | Class II | Voriconazole | Terminated |
| 2024-01-05 | Class II | Rifampin | Terminated |
| 2024-01-05 | Class II | Rifampin | Terminated |
| 2024-01-03 | Class II | Cefixime | Terminated |
| 2023-12-20 | Class II | Desloratadine | Terminated |
| 2023-11-22 | Class II | Penicillamine | Terminated |
| 2023-06-27 | Class III | Amlodipine Besylate | Terminated |
| 2023-06-23 | Class I | Tydemy | Terminated |
| 2023-01-20 | Class III | Clobetasol Propionate | Terminated |
| 2022-12-12 | Class II | Rifampin | Terminated |
| 2022-12-07 | Class II | Quinapril | Terminated |
| 2022-12-07 | Class II | Quinapril | Terminated |
| 2022-09-13 | Class II | Lisinopril | Terminated |
| 2022-07-28 | Class II | Rifampin | Terminated |
| 2022-06-10 | Class II | Zileuton Extended-Release Tablets, 600 mg, 120-count bottle, Rx only, Manufactured for Lup | Terminated |
| 2022-04-27 | Class II | Gavilyte - C | Terminated |
| 2022-03-31 | Class II | Losartan Potassium And Hydrochlorothiazide | Terminated |
| 2022-03-31 | Class II | Losartan Potassium And Hydrochlorothiazide | Terminated |
| 2022-03-31 | Class II | Losartan Potassium | Terminated |
| 2022-03-31 | Class II | Losartan Potassium And Hydrochlorothiazide | Terminated |
| 2022-03-31 | Class II | Losartan Potassium | Terminated |
| 2022-03-31 | Class II | Losartan Potassium | Terminated |
| 2021-12-29 | Class III | Oxycodone Hydrochloride | Terminated |
| 2021-12-22 | Class III | Gatifloxacin Ophthalmic Solution, 0.5%, 2.5 mL bottle, Rx only, Manufactured by: Lupin Lim | Terminated |
| 2021-11-19 | Class III | Tydemy (drospirenone, ethinyl estradiol & levomefolate calcium tablets, 3 mg/0.03 mg/0.451 | Terminated |
| 2021-10-20 | Class III | Gatifloxacin Ophthalmic Solution, 0.5%, 2.5 mL bottle, Rx only, Manufactured by: Lupin Lim | Terminated |
| 2021-10-12 | Class II | Irbesartan and Hydrochlorothiazide Tablets USP, 300/12.5 mg a) 30 count (NDC 68180-414-06 | Terminated |
| 2021-10-12 | Class II | Irbesartan | Terminated |
| 2021-10-12 | Class II | Irbesartan | Terminated |
| 2021-10-12 | Class II | Irbesartan | Terminated |
| 2021-10-12 | Class II | Irbesartan and Hydrochlorothiazide Tablets USP, 150/12.5 mg a) 30 count (NDC 68180-413-06 | Terminated |
| 2021-10-08 | Class II | Imipramine Pamoate | Terminated |
| 2021-04-29 | Class II | Cefixime | Terminated |
| 2021-03-26 | Class II | Cefprozil | Terminated |
| 2021-01-21 | Class III | Oseltamivir Phosphate | Terminated |
| 2020-07-21 | Class II | Mibelas 24 Fe (norethindrone acetate and ethinyl estradiol tablets and ferrous fumarate ta | Terminated |
| 2020-07-17 | Class II | Lisinopril | Terminated |
| 2020-07-07 | Class II | Metformin Hydrochloride | Terminated |
| 2020-07-07 | Class II | Metformin Hydrochloride | Terminated |
| 2020-07-07 | Class II | Metformin Hydrochloride | Terminated |
| 2020-07-07 | Class II | Metformin Hydrochloride | Terminated |
| 2020-07-02 | Class II | Cefdinir | Terminated |
| 2020-06-11 | Class II | Metformin Hydrochloride | Terminated |
| 2020-05-28 | Class II | Lisinopril | Terminated |
| 2020-04-20 | Class II | Lisinopril Tablets USP, 20 mg, 1000-count bottle, Rx Only, Manufactured for: Lupin Pharmac | Terminated |
| 2020-04-15 | Class II | Cefixime | Terminated |
| 2020-04-01 | Class II | Lisinopril | Terminated |
| 2020-03-09 | Class III | Bekyree (desogestrel and ethinyl estradiol tablets USP, 0.15 mg/0.02 mg and ethinyl estrad | Terminated |
| 2020-03-09 | Class II | Levonorgestrel and Ethinyl Estradiol Tablets USP, 0.05mg/0.03 mg, 0.075mg/0.04mg, and 0.12 | Terminated |
| 2020-02-19 | Class II | Desoximetasone Topical Spray, 0.25%, 2.5 mg desoximetasone, 100 mL bottles, Rx only, Manuf | Terminated |
| 2020-02-12 | Class II | Memantine Hydrochloride | Terminated |
| 2020-01-10 | Class III | Tri-Lo-Marzia (Norgestimate and Ethinyl Estradiol Tablets, USP), 0.180 mg/0.025 mg; 0.215m | Terminated |
| 2019-12-26 | Class II | Blisovi Fe 1.5/30 (norethindrone acetate and ethinyl estradiol tablets USP and ferrous fu | Terminated |
| 2019-12-13 | Class III | Bimatoprost Ophthalmic Solution, 0.03%, For Use in the Eyes Only, Sterile, Rx Only, 7.5 mL | Terminated |
| 2019-12-10 | Class III | Memantine Hydrochloride | Terminated |
| 2019-11-01 | Class III | Cephalexin for Oral Suspension USP, 250 mg/5mL, 200 mL bottle, Rx only, Manufactured for: | Terminated |
| 2019-11-01 | Class III | Cefdinir | Terminated |
| 2019-11-01 | Class III | Cefdinir | Terminated |
| 2019-07-19 | Class II | Lisinopril And Hydrochlorothiazide | Terminated |
| 2019-07-17 | Class II | Lisinopril And Hydrochlorothiazide | Terminated |
| 2019-07-17 | Class III | Nystatin And Triamcinolone Acetonide | Terminated |
| 2019-07-11 | Class III | Gatifloxacin Ophthalmic Solution 0.5%, For Use in the Eyes Only, Rx Only, Sterile, 2.5 mL | Terminated |
| 2019-07-02 | Class II | Kaitlib Fe norethindrone and ethinyl estradiol chewable tablets (0.8 mg/0.025 mg) and Ferr | Terminated |
| 2019-05-23 | Class II | Cefdinir | Terminated |
| 2019-04-01 | Class III | Telmisartan And Amlodipine | Terminated |
| 2019-03-22 | Class II | Fayosim (levonorgestrel and ethinyl estradiol) tablets USP, (0.15 mg/0.02 mg, 0.15 mg/0.02 | Terminated |
| 2019-03-13 | Class III | Testosterone | Terminated |
| 2019-02-26 | Class III | Moxifloxacin | Terminated |
| 2019-02-13 | Class III | Lovastatin | Terminated |
| 2019-02-01 | Class III | Moxifloxacin | Terminated |
| 2019-01-28 | Class III | Bimatoprost Ophthalmic Solution 0.03%, packaged in a) 5 mL (NDC 68180-429-02) and b) 7.5 m | Terminated |
| 2019-01-09 | Class II | Cephalexin | Terminated |
| 2019-01-07 | Class II | Cephalexin for Oral Suspension USP, 250mg/5mL, 200 mL (when mixed), Rx only, Manufactured | Terminated |
| 2019-01-02 | Class II | Cefdinir | Terminated |
| 2019-01-02 | Class II | Cefdinir | Terminated |
| 2018-12-20 | Class I | Ceftriaxone for Injection USP, 1 g, packaged in a) one Single Use Vial (NDC 68180-633-01) | Terminated |
| 2018-12-20 | Class I | Ceftriaxone for Injection USP, 500 mg, packaged in a) one Single Use Vial (NDC 68180-622-0 | Terminated |
| 2018-12-20 | Class I | Ceftriaxone for Injection USP, 250 mg, packaged in a) one Single Use Vial (NDC 68180-611-0 | Terminated |
| 2018-12-20 | Class I | Ceftriaxone for Injection USP, 2 g, packaged in 10 Single Use Vials (NDC 68180-644-01) per | Terminated |
| 2018-10-09 | Class III | Testosterone | Terminated |
| 2018-08-13 | Class II | Lisinopril | Terminated |
| 2018-07-26 | Class III | Moxifloxacin | Terminated |
| 2018-05-17 | Class II | My Way (Levonorgestrel) Tablets TWO PACK, 1.5 mg each, packaged as 2 Treatments (Two 1.5mg | Terminated |
| 2018-05-17 | Class II | My Way (levonorgestrel) Tablets TWO PACK, 1.5 mg each, packaged as 2 Treatments (Two 1.5mg | Terminated |
| 2018-03-27 | Class II | Cefdinir | Terminated |
| 2017-11-21 | Class III | Duloxetine | Terminated |
| 2017-06-22 | Class III | Paroxetine | Terminated |
| 2017-05-02 | Class III | Famotidine | Terminated |
| 2016-04-06 | Class III | Lisinopril | Terminated |
| 2016-04-06 | Class III | Lisinopril | Terminated |
| 2016-04-04 | Class III | Lisinopril And Hydrochlorothiazide | Terminated |
| 2016-03-11 | Class III | Ceftriaxone Sodium (Sterile) USP active pharmaceutical ingredient, DMF No. 15931; Manufact | Terminated |
| 2016-03-11 | Class III | Ceftriaxone for Injection USP, 1 g, Single Use Vial (NDC 68180-633-01) packaged in 10-coun | Terminated |
| 2016-03-11 | Class III | Ceftriaxone for Injection USP, 500 mg, Single Use Vial, packaged in a) 1-count Vials per b | Terminated |
| 2016-03-11 | Class III | Ceftriaxone for Injection USP, 2 g, Single Use Vial (NDC 68180-644-01) packaged in 10-coun | Terminated |
| 2016-03-11 | Class III | Ceftriaxone for Injection USP, 250 mg, Single Use Vial, packaged in a) 1-count Vials per b | Terminated |
| 2015-12-07 | Class III | Quinapril | Terminated |
| 2014-01-27 | Class III | Suprax, Cefixime for Oral Suspension USP, 500 mg/5 ml, 20 mL (when reconstituted), Rx onl | Terminated |
| 2014-01-27 | Class III | Suprax, Cefixime for Oral Suspension USP 500 mg/5 ml, 10mL (when reconstituted), Rx only, | Terminated |
| 2013-09-17 | Class II | Quinapril | Terminated |
| 2013-09-17 | Class II | Quinapril | Terminated |
| 2013-02-22 | Class III | Ethambutol Hydrochloride | Terminated |
| 2013-01-31 | Class III | Suprax (cefixime for oral suspension) USP, 100 mg/5 mL, 50 mL bottles (when reconstituted) | Terminated |